BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3106234)

  • 1. [Prevention using a Pseudomonas immunoglobulin in burn patients].
    Stuttmann R; Petrovici V; Hartert M
    Infection; 1987; 15(1):80-4. PubMed ID: 3106234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pseudomonas immunoglobulin prophylaxis in patients with burn injuries].
    Stuttmann R; Petrovici V; Hartert M
    Infection; 1987; 15 Suppl 2():S71-5. PubMed ID: 3112025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinical trial of i.v. tetravalent hyperimmune Pseudomonas globulin G in burned patients.
    Hunt JL; Purdue GF
    J Trauma; 1988 Feb; 28(2):146-51. PubMed ID: 3126302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevention with pseudomonas immune globulin in burn injury patients with inhalation trauma: does it have an effect on lung function and outcome?].
    Stuttmann R; Hebebrand D; Hartert M; Spilker G; Doehn M
    Klin Wochenschr; 1991; 69 Suppl 26():168-77. PubMed ID: 1813715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Pseudomonas immunoglobulin. III. Preliminary clinical evaluation.
    Sakiel S; Schiller B; Buchowicz I; Kotkowska-Tomanek E
    Arch Immunol Ther Exp (Warsz); 1983; 31(4):517-21. PubMed ID: 6422901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Passive immunisation against Pseudomonas aeruginosa recombinant flagellin in an experimental model of burn wound sepsis.
    Faezi S; Sattari M; Mahdavi M; Roudkenar MH
    Burns; 2011 Aug; 37(5):865-72. PubMed ID: 21334822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled trial of Pseudomonas immunoglobulin and vaccine in burn patients.
    Jones RJ; Roe EA; Gupta JL
    Lancet; 1980 Dec; 2(8207):1263-5. PubMed ID: 6108445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active and passive immunization against Pseudomonas aeruginosa infection of burned patients.
    Roe EA; Jones RJ
    Burns Incl Therm Inj; 1983 Jul; 9(6):433-9. PubMed ID: 6412970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of Pseudomonas immunoglobulin in artificially respirated patients at an interdisciplinary surgical intensive care unit].
    Class I; Junginger W; Klöss T
    Infection; 1987; 15(1):76-9. PubMed ID: 3106233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization of burned patients against Pseudomonas aeruginosa infection at Safdarjang Hospital, New Delhi.
    Roe EA; Jones RJ
    Rev Infect Dis; 1983; 5 Suppl 5():S922-30. PubMed ID: 6419315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective activity of an intravenous immune globulin (human) enriched in antibody against lipopolysaccharide antigens of Pseudomonas aeruginosa.
    Collins MS; Roby RE
    Am J Med; 1984 Mar; 76(3A):168-74. PubMed ID: 6424446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of antibodies against the N-terminal of Pseudomonas aeruginosa flagellin for treating infections in a murine burn wound model.
    Barnea Y; Carmeli Y; Gur E; Kuzmenko B; Gat A; Neville LF; Eren R; Dagan S; Navon-Venezia S
    Plast Reconstr Surg; 2006 Jun; 117(7):2284-91. PubMed ID: 16772930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Pseudomonas aeruginosa activity of an intravenous human IgG preparation in burned mice.
    Collins MS; Roby RE
    J Trauma; 1983 Jun; 23(6):530-4. PubMed ID: 6408266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of passive immunotherapy in the treatment of experimental Pseudomonas aeruginosa infections in burns.
    Neely AN; Holder IA
    Antibiot Chemother (1971); 1987; 39():26-40. PubMed ID: 3118788
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prevention of gram-negative and gram-positive infections using 3 intravenous immunoglobulin preparations and therapy of experimental polymicrobial burn infection using intravenous Pseudomonas immunoglobulin G and ciprofloxacin in an animal model].
    Collins MS; Hector RF; Roby RE; Edwards AA; Ladehoff DK; Dorsey JH
    Infection; 1987; 15(1):60-8. PubMed ID: 3570485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of locally delivered polyclonal immunoglobulin against Pseudomonas aeruginosa infection in a murine burn wound model.
    Felts AG; Giridhar G; Grainger DW; Slunt JB
    Burns; 1999 Aug; 25(5):415-23. PubMed ID: 10439150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of pseudomonas immunoglobulin in ventilated patients at an interdisciplinary surgical intensive care station].
    Class I; Junginger W; Klöss T
    Infection; 1987; 15 Suppl 2():S67-70. PubMed ID: 3112024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active and passive immunization strategies for Pseudomonas aeruginosa pneumonia.
    Pennington JE; Pier GB; Sadoff JC; Small GJ
    Rev Infect Dis; 1986; 8 Suppl 4():S426-33. PubMed ID: 2944209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention of gram-negative and gram-positive infections with 3 intravenous immunoglobulin preparations and therapy of experimental polymicrobial burn infection with intravenous Pseudomonas immunoglobulin G and ciprofloxacin in an animal model].
    Collins MS; Hector RF; Roby RE; Edwards AA; Ladehoff DK; Dorsey JH
    Infection; 1987; 15 Suppl 2():S51-9. PubMed ID: 3112021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative anti-Pseudomonas aeruginosa activity of chemically modified and native immunoglobulin G (human), and potentiation of antibiotic protection against Pseudomonas aeruginosa and group B Streptococcus in vivo.
    Collins MS; Dorsey JH
    Am J Med; 1984 Mar; 76(3A):155-60. PubMed ID: 6424444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.